Our doctors are leading the way in advancing the field of retina medicine and surgery through research and clinical trials. We participate in studies conducted by the National Institutes of Health (NIH), the National Eye Institute (NEI), and the Food and Drug Administration (FDA). Our physicians serve as principal investigator or co-investigator in clinical trials that cover many aspects of vitreoretinal disease and treatment.
We are currently participating in the following clinical trials with the singular goal of preserving the gift of sight.
TOGA Study: Evaluates the efficacy of Oracea (a drug that was originally prescribed for the treatment of rosacea) in patients that suffer from Geographic Atrophy and Dry AMD (also known as non-exudative AMD).
Allergan Study: This study assesses the usefulness of the drug, Abicipar Pegol, in patients that suffer from Wet, Age-Related Macular Degeneration (also known as neovascular AMD).
Diabetic Retinopathy Clinical Research Network: This study explores the effectiveness of different treatment plans for patients with Central-Involved Diabetic Macular Edema who continue to have very good visual acuity.